{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/724-US10,975,364(Active) re (Done on website already).pdf"}, "page_content": "indels\n\non\n\ntion\n\n15\n\n20\n\n25\n\n40\n\n45\n\n50\n\n35\n\n60\n\n65\n\nby\n\nis\n\nby\n\nby\n\n8\n\nby\n\nby\n\nUS 10,975,364 B2\n\n5\n\n6\n\nFIG . 5D shows GUIDE - Seq detected cleavage sites by a\n\nPAM ) may be inversely correlated with the proportion of\n\nmodified protein comprising mutations at E782 , N968 and\n\nSaCas9 in an activated state and that wild - type SaCas9\n\nR1015 positions ( indicated as \u201c KKH \u201d in the figure ) and a\n\namino acid residues in proximity of the guide RNA - target\n\nmodified protein with mutations at E782 , N968 , R1015 ,\n\nDNA heteroduplex could lower the threshold for activating\n\nR245 , N413 , N419 and R654 positions comprising an amino 5 the Cas9 nuclease domain , thus resulting in potentially more\n\nacid sequence as defined in SEQ ID NO : 4 ( KKH - SaCas9-\n\nbinding at off - target sites .\n\nHF , indicated as \u201c KKH - HF \u201d in the figure ) when targeting six\n\nThe modified protein as described herein advantageously\n\nsites with non - canonical NNNRRT PAM . Read counts listed\n\nprovides an improved Cas9 protein with reduced nuclease\n\non the right represent the number of GUIDE - Seq reads .\n\nactivity at one or more sites on a target DNA molecule ,\n\nOn - target site is indicated with \u201c * \u201d . Mismatched bases in 10 specifically at one or more off - target sites on a target DNA\n\noff - target sites with the on - target site are highlighted .\n\nmolecule , such that off - target activities and undesired off\n\ntarget mutations on the target DNA molecule are reduced .\n\nThe term \" off - target sites \u201d as used herein refers to non\n\nDETAILED DESCRIPTION OF THE\n\nspecific binding of the modified protein at locations other\n\nEMBODIMENTS\n\n15 than the predetermined target sequence . The term \u201c on - target\n\nUnless otherwise defined , all technical terms used herein\n\nsites \u201d used herein refers to binding of the modified protein\n\nhave the same meaning as commonly understood by one\n\nat the predetermined target sequence . On - target and off\n\ntarget site binding may be compared at various target sites ,", "type": "Document"}}